Clinic-Based AMES Treatment of Stroke


Phase 1/2 Results


Most subjects improved on most tests, and gains were sustained for 6 months in most subjects. No safety problems arose. In conclusion, the AMES strategy appears safe and possibly effective in patients with severe chronic impairments. The mechanism underlying these gains is likely to be multifactorial.